Scilex Holding Company Announces Worldwide Exclusive License for Tokenization and Monetization of Real-World Asset (RWA) in Genomic, DNA Data, Diagnosis, Therapeutics Products ...

Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for ...
Fierce Biotech

New in vivo gene editing biotech blossoms from CRISPR pioneer Jennifer Doudna's lab with $82M

A new West Coast biotech has emerged into the busy in vivo cell therapy space, this time with the backing of Nobel Prize-winning CRISPR pioneer Jennifer Doudna, Ph.D. Azalea Therapeutics has bloomed ...

SOHM Notes FDA's Evolving Gene-Editing Framework in Context of Ongoing ABBIE Platform Development

CHINO HILLS, CALIFORNIA / ACCESS Newswire / November 4, 2025 / SOHM, Inc. (OTCID:SHMN), a pharmaceutical and biotechnology company specializing in generic drugs and gene-editing tools, a leader in ...

Biotech stocks are coming back. Here's what's driving the sector higher.

2. Mergers and acquisitions are picking up: So far this year, buyouts have boosted several biotech stocks. Some standouts: Regulus Therapeutics went up 120%; 89bio went up 85%; Chimerix gained 69% and ...
Le Lézard

8x8, Inc. Announces Second Quarter Fiscal Year 2026 Financial Results

Inc. , a leading global business communications platform provider, today reported financial results for the second quarter of fiscal year 2026 ended September 30, 2025. "Our second quarter performance ...